S-2 1. General methods for synthesis and analysis All solvents and reagents were purchased from commercial suppliers (Aldrich, Fluka, TCI), and used without further purification including folic acid dihydrate (Sigma; purity 98%), and doxorubicin hydrochloride (AvaChem Scientific LLC, San Antonio, TX; purity 98.0%). Reactions were run under nitrogen atmosphere unless noted otherwise. Progress of reactions was monitored by thin layer chromatography on Merck® TLC plates (250 μm thick), and spots were detected by UV illumination at 254 or 365 nm or by staining with phosphomolybdic acid reagent (20% w/v in ethanol) or ninhydrin solution (5% w/v in 3% acetic acid/ethanol). Reaction mixtures were worked up as described specifically in each reaction including flash column chromatography using silica gel (200-400 mesh).
Characterization of reaction products was routinely carried out by 1 H NMR spectroscopy and mass spectrometry. For NMR ( 1 H, 13 C) measurement, samples were dissolved in deuterated solvent (CDCl 3 , CD 3 OD, D 2 O, DMSO-d 6 ), and NMR spectra were acquired with a Varian nuclear magnetic resonance spectrometer at 400 MHz or 300 MHz for 1 H NMR spectra, and at 100 MHz for 13 C NMR spectra under standard observation conditions. Mass spectrometric identification of compounds was performed by electrospray ionization mass spectrometry (ESI-MS) with a Micromass AutoSpec Ultima spectrometer.
Molecular weights of PAMAM G5 dendrimer and its conjugates were measured by matrix assisted laser desorption ionization-time of flight (MALDI-TOF) with a Waters TOfsPec-2E spectrometer. The MALDI spectra were acquired using a matrix solution of 2,5-dihydroxybenzoic acid (10 mg/ml in 50% aqueous acetonitrile) in a linear mode with a high mass detector. The spectrometer was mass calibrated with BSA in sinapinic acid, and data was acquired and processed using Mass Lynx 3.5 software. UV-vis absorption spectra were recorded on a Perkin Elmer Lamda 20 spectrophotometer.
HPLC analysis was carried out on a Waters Acquity Peptide Mapping System equipped with a Waters photodiode array detector, a column manager that facilitates 4 column housing, and a sample manager (referred to Ultra Performance Liquid Chromatography). For analysis the PAMAM dendrimer conjugates were run on a C4 BEH column (150 x 2.1 mm, 300 Å) connected to Waters Vanguard column. Elution of the conjugates was performed in a linear gradient beginning with 98:2 (v/v) water/acetonitrile (with trifluoroacetic acid at 0.14 wt % in each of the eluents) at a flow rate of 1 mL/min.
Size exclusion chromatography (SEC) was used to measure molecular weights and polydispersity index (PDI) of PAMAM G5 dendrimer. The GPC experiments were performed on an S-3 employed were TosoHaas TSK-Gel Guard PHW 06762 (75 mm × 7.5 mm, 12 mm), G 2000 PW 05761
(300 mm × 7.5 mm, 10 mm), G 3000 PW 05762 (300 mm × 7.5 mm, 10 mm), and G 4000 PW (300 mm × 7.5 mm, 17 mm). Column temperature was maintained at 25 ± 0.1 °C with a Waters temperature control module. The isocratic mobile phase was 0.1 M citric acid and 0.025 wt % sodium azide, pH 2.74, at a flow rate of 1 mL/min. The sample concentration was 10 mg/5 mL. The weight average molecular weight, Mw, has been determined by GPC, and the number average molecular weight, Mn, was calculated with Astra 5.3.14 software (Wyatt Technology Corporation) based on the molecular weight distribution.
Synthesis of 1
Folic acid-ethylenediamine amide was prepared according to a literature procedure (Whiteley, J.M.,
Henderson, G. B., Russell, A., Singh, P., Zevely, E. M. Anal. Biochem. 1977, 79, 42-51) . To a stirred solution of folic acid dihydrate (1.0 g, 1.94 mmol) in DMF (120 mL) was added 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (2.0 g, 10.4 mmol). After stirring for 1 h in the dark, 178.52, 175.77, 174.63, 172.97, 170.16, 169.26, 163.88, 155.35, 151.13, 150.93, 147.21, 147.09, 129.09, 128.85, 128.04, 121.32, 120.72, 112.47, 112.32, 55.64, 55.04, 54.97, 45.70, 43.61, 41.70, 39.65, 39.50, 33.72, 32.61, 27.72, 27.57 190.75, 167.98, 152.49, 149.94, 131.11, 126.06, 112.33, 109.84, 65.91, 61.58, 56.04, 14 .08 ppm.
Step (ii): To a solution of 2-(4-formyl-2-methoxy-phenoxy)acetic acid ethyl ester (11.8 g, 49.5 mmol) in a mixture of THF (50 mL) and MeOH (100 mL) was added slowly sodium hydroxide (9.9 g, 248 mol) dissolved in water (100 mL). The mixture was stirred for 33 h at rt, and then evaporated to remove volatile organic solvents in vacuo. The aqueous residue was acidified to pH~3 by adding conc HCl (~21 mL) slowly and resulting precipitates were collected on a Büchner funnel. The solid was washed with water, rinsed with ethyl acetate, and dried to afford product 2, 2-(4-formyl-2-methoxyphenoxy)acetic acid, as white solid (8.5 g, 82% 
3:
Step (iii): To a stirred conc. HNO 3 (70%; 100 mL) cooled in ice bath was added acetic acid (10 mL), and 2-(4-formyl-2-methoxy-phenoxy)acetic acid 2 (6 g, 28.4 mmol) as solid. The mixture was stirred at the same temperature for 2 h, and gradually warmed to rt. After stirring for 26 h, the reaction solution was poured into ice (~500 mL), and left overnight at rt while the product was precipitated as bright yellow solid. It was collected, washed with copious volume of water, and dried to afford 2-(4-formyl-2-methoxy-5-nitrophenoxy)acetic acid (4.95 g, 68% Step (iv): To a cold solution of 2-(4-formyl-2-methoxy-5-nitrophenoxy)acetic acid (2.6 g, 10.2 mmol) in a mixture of CHCl 3 (95 mL) and DMF (5 mL) in ice bath was added 4-dimethylaminopyridine (248 mg, 2.03 mmol), 2-(N-tert-butoxycarbonylamino)ethylamine (1.63 g, 10.2 mmol), and finally dicyclohexylcarbodiimide (2.3 g, 11.1 mmol) as solid. The mixture was stirred at 5 o C for 2 h and then warmed to rt where it continued to be stirred for 36 h. The mixture was filtered to remove urea byproduct, and the filtrate was evaporated to dryness in vacuo yielding pale yellow residue. It was
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S-5 dissolved in EtOAc (200 mL), and washed with 1M H 3 PO 4 , saturated NaHCO 3 , and brine solution. The organic layer was dried over Na 2 SO 4 , and evaporated to afford 2-(4-formyl-2-methoxy-5- Step (v): To a solution of 2-(4-formyl-2-methoxy-5-nitrophenoxy)-N-(2-(N-tertbutoxycarbonylamino)ethylamine)acetamide (2.2 g, 5.52 mmol) in a mixture of THF (10 mL) and MeOH (60 mL) was added sodium borohydride (104 mg, 2.75 mmol) slowly. After stirring the mixture for 5 h, the reaction was quenched by adding water (5 mL) and stirring it for 10 min. The mixture was evaporated in vacuo, and the residue was dissolved in 5% MeOH in CHCl 3 (10 mL). The solution was loaded onto a silica flash column and eluted with MeOH/CHCl 3 (2 to 5%). Product 3, 2-(4- 
4:
Step ( 24, 154.23, 146.38, 138.69, 126.98, 125.36, 121.66, 112.77, 111.84, 111.02, 68.80, 67.44 
5:
Step (viii): To 4 (25 mg, 25.8 μmol) was added a mixture of CHCl 3 (1.0 mL) and TFA (0.5 mL). The mixture was stirred at rt for 15 min, and evaporated to dryness in vacuo. S-7 100. 1 H NMR (400 MHz, D 2 O): δ = 3.28-3.2 (br), 3.14 (br s), 2.9-2.76 (br), 2.74-2.6 (br), 2.42-2.3 (br), 2.09-2.07 (br t), 2.03-1.99 (br t), 1.66-1.62 (br t) ppm.
(PAMAM G5-FA-doxorubicin):
To a suspension of 6 (PAMAM G5-glutaric acid; 40 mg) in anhydrous DMF (10 mL) was added 4-dimethylaminopyridine (12 mg, 98.3 μmol), Nhydroxysuccinimide (12 mg, 104 μmol), and 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (20 mg, 104 μmol). The mixture was stirred at rt for 36 h, and followed by the addition of 1 (folic acid-linker; 9.9 mg, 20.0 μmol) and 5 (freshly prepared from 25 mg of 4, 25.8 μmol). Then triethylamine (54 μL, 387 μmol) was added to the reaction mixture to adjust the solution to be slightly basic (pH~9). The mixture was stirred at rt for 36 h in the dark prior to the addition of water (2 mL).
After stirring for 4 h at rt, the mixture was concentrated to a volume of ~2 mL, and diluted with water Average number of folate ligand and doxorubicin attached to the surface of PAMAM G5-glutaric acid was estimated to be ~8 (1) and ~4 (5) respectively from the analysis of the relative ratio between 1 and 5 in 1 H NMR spectral data in combination with their contribution to the increase in molecular weight of 7 relative to 6 (Δ = 48000 − 40200 = 7800). for 36 h, and followed by the addition of 5 (prepared from 13.2 mg of 4, 13.6 μmol) and FITC-NH(CH 2 ) 4 -NH 2 (3.6 mg, 7.5 μmol). Then triethylamine (9 μL, 65 μmol) was added to the reaction mixture to adjust the solution to be slightly basic (pH~9). The mixture was stirred at rt for 24 h in the dark, and then 1 (6 mg, 12.1 μmol) dissolved in DMF (2 mL) was added. After stirring for 24 h, water
(PAMAM G5
-
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S-8 (2 mL) was added to quench the coupling reaction. After stirring for 4 h, the mixture was concentrated to a volume of ~2 mL, and diluted with water (15 mL). The solution was added into a into a membrane Photolysis experiments were carried out using Spectroline® UV bench lamps (XX-15A) at long wavelength (320-400 nm) with a maximum intensity at 365 nm. Linker 3 or PAMAM G5
nanoconjugate 7 was dissolved in phosphate-based saline solution (PBS, pH 7.2) unless specified otherwise. Each of the solution contained in a Petri dish was placed without any cover under UV lamps at the distance of ~ 5 cm from lamps, and irradiated over up to 14 min. Progress of the photolysis was monitored by analyzing an aliquot (700 μL) from each irradiated solution at specific time by UV-vis spectrometry and analytical HPLC.
5a. UV-vis absorption spectra of photolinker 3 before and after UV exposure. An aqueous solution of 3 (33 μM in 0.5% MeOH/H 2 O) was exposed to long wavelength UV over specified time (t = 0 to 12 min) and measured for UV-vis spectra.
5b. Time course of photolysis of 3. A plot of absorbance at λ max (340 nm) against irradiation time. S-10 middle, indicating an uneven distribution of PAMAM doxorubicin dendrimers; (b) HPLC chromatograms after UV irradiation (t = 2 to 6 min). Please note that the current HPLC method allowed to monitor the progress of the photolysis over time, but was unable to separate doxorubicin from a distribution of dendrimer conjugates, both assigned to a broad peak. 
In vitro cell based assays
In vitro cytotoxicity assay. It was measured in KB cells, a sub-line of the cervical carcinoma HeLa cells (ATCC, Manassas, VA, USA). The cells were grown as a monolayer cell culture at 37 °C and 5% CO 2 in folic acid-deficient RPMI 1640 medium supplemented with 10% fetal bovine serum (FBS). The 10% FBS provided folic acid concentration equivalent to that is present in the human serum (~20 nM). Cells were seeded in 96-well microtiter plates (3000 cells/well) and two days after plating, they were rinsed with phosphate buffered saline containing 0.1% bovine serum albumin (PBSB). The cells were then covered with 50 μL of each PBSB in the presence or absence of 3 μM each of 7
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(PAMAM G5-FA-Dox) or doxorubicin. The plates were exposed to UV light (Spectroline® UV bench lamp XX-15A: 320-400 nm, power = 1.1 mW/cm 2 ) kept ~ 1 cm above from the bottom of the plate for different time periods. The control (zero time) plate was incubated under normal light in parallel.
Following the exposure to light, the cells were supplemented with 150 μL each of RPMI medium containing 10% serum and incubated for 24 h, changed to fresh medium and allowed to grow for another 4 days. For cytotoxicity measurement, a colorimetric XTT (sodium 3-[1-(phenylaminocarbonyl)-3,4-tetrazolium]-bis(4-methoxy-6-nitro)benzene sulfonic acid hydrate; Roche Molecular Biochemicals, Indianapolis, IN) assay was performed following the vendor's protocol. After incubation with the XTT labeling mixture, the microtiter plates were read on an ELISA reader (Synergy HT, BioTek) at 492 nm with the reference wavelength at 690 nm. and FITC (green) fluorescence were measured using a confocal microscope. Some cells were preincubated with 50 uM of free FA for 15 min prior to adding the dendrimer conjugates.
7a. 1 H NMR spectra of 4, 3, and 7, and HRMS of 5.
